Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:acetate salt
go back to main search page
Accession:CHEBI:59230 term browser browse the term
Definition:Any salt prepared using acetic acid as the acid component.
Synonyms:related_synonym: acetate salts


show annotations for term's descendants           Sort by:
 
ammonium acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADA adenosine deaminase increases activity ISO ammonium acetate results in increased activity of ADA protein CTD PMID:19900420 NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,619,522...44,652,233
JBrowse link
G AMPD2 adenosine monophosphate deaminase 2 increases activity ISO ammonium acetate results in increased activity of AMPD2 protein CTD PMID:19900420 NCBI chr 1:109,619,837...109,632,055
Ensembl chr 1:109,616,104...109,632,053
JBrowse link
G AMPD3 adenosine monophosphate deaminase 3 increases activity ISO ammonium acetate results in increased activity of AMPD3 protein CTD PMID:19900420 NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
JBrowse link
G ASL argininosuccinate lyase increases activity ISO ammonium acetate results in increased activity of ASL protein CTD PMID:16009439 NCBI chr 7:66,075,819...66,093,576
Ensembl chr 7:66,075,800...66,094,697
JBrowse link
G ASS1 argininosuccinate synthase 1 increases activity ISO ammonium acetate results in increased activity of ASS1 protein CTD PMID:16009439 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
JBrowse link
G CAT catalase increases activity
decreases activity
multiple interactions
ISO ammonium acetate results in increased activity of CAT protein
ammonium acetate results in decreased activity of CAT protein
Dizocilpine Maleate inhibits the reaction [ammonium acetate results in decreased activity of CAT protein]
CTD PMID:12885441, PMID:15945352 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G GRIN2A glutamate ionotropic receptor NMDA type subunit 2A multiple interactions
decreases expression
ISO Allopurinol inhibits the reaction [ammonium acetate results in decreased expression of GRIN2A protein] CTD PMID:20084674 NCBI chr16:9,753,404...10,182,928
Ensembl chr16:9,753,404...10,182,928
Ensembl chr16:9,753,404...10,182,928
JBrowse link
G GRIN2B glutamate ionotropic receptor NMDA type subunit 2B decreases expression ISO ammonium acetate results in decreased expression of GRIN2B protein CTD PMID:20084674 NCBI chr12:13,537,337...13,982,012
Ensembl chr12:13,437,942...13,982,002
Ensembl chr12:13,437,942...13,982,002
JBrowse link
G HMOX1 heme oxygenase 1 increases expression ISO ammonium acetate results in increased expression of HMOX1 protein CTD PMID:12420312 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,207
JBrowse link
G MAOA monoamine oxidase A increases activity
multiple interactions
ISO ammonium acetate results in increased activity of MAOA protein
Dizocilpine Maleate inhibits the reaction [ammonium acetate results in increased activity of MAOA protein]
CTD PMID:12885441 NCBI chr  X:43,655,006...43,746,817
Ensembl chr  X:43,654,907...43,746,824
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases expression
multiple interactions
ISO ammonium acetate results in increased expression of PARP1 protein
Cycloheximide inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein]; Dizocilpine Maleate inhibits the reaction [ammonium acetate results in increased expression of PARP1 protein]
CTD PMID:15147502 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,691...226,408,093
JBrowse link
G SOD2 superoxide dismutase 2 decreases activity
multiple interactions
ISO ammonium acetate results in decreased activity of SOD2 protein
Dizocilpine Maleate inhibits the reaction [ammonium acetate results in decreased activity of SOD2 protein]
CTD PMID:12885441 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
Ensembl chr 6:159,669,069...159,762,529
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G XDH xanthine dehydrogenase affects activity
multiple interactions
ISO ammonium acetate affects the activity of XDH protein
Dizocilpine Maleate inhibits the reaction [ammonium acetate affects the activity of XDH protein]
CTD PMID:12885441 NCBI chr 2:31,334,320...31,414,777
Ensembl chr 2:31,334,321...31,414,742
JBrowse link
cobalt(II) acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HIF1A hypoxia inducible factor 1 subunit alpha increases expression EXP cobalt(II) acetate results in increased expression of HIF1A protein CTD PMID:16357179 NCBI chr14:61,695,513...61,748,259
Ensembl chr14:61,695,513...61,748,259
JBrowse link
lead tetraacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G APP amyloid beta precursor protein decreases expression ISO lead tetraacetate results in decreased expression of APP mRNA CTD PMID:20865013 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,550...26,171,128
JBrowse link
G MAPT microtubule associated protein tau decreases expression ISO lead tetraacetate results in decreased expression of MAPT mRNA CTD PMID:20865013 NCBI chr17:45,894,538...46,028,334
Ensembl chr17:45,894,551...46,028,334
Ensembl chr17:45,894,551...46,028,334
JBrowse link
G NRXN1 neurexin 1 decreases expression ISO lead tetraacetate results in decreased expression of NRXN1 mRNA CTD PMID:20865013 NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
JBrowse link
G PRNP prion protein decreases expression ISO lead tetraacetate results in decreased expression of PRNP mRNA CTD PMID:20865013 NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
JBrowse link
G SYP synaptophysin decreases expression ISO lead tetraacetate results in decreased expression of SYP mRNA CTD PMID:20865013 NCBI chr  X:49,187,815...49,200,193
Ensembl chr  X:49,187,815...49,200,199
Ensembl chr  X:49,187,815...49,200,199
JBrowse link
G TUBB3 tubulin beta 3 class III decreases expression ISO lead tetraacetate results in decreased expression of TUBB3 mRNA CTD PMID:20865013 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
thallium(I) acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SOD1 superoxide dismutase 1 decreases activity ISO thallium acetate results in decreased activity of SOD1 protein CTD PMID:15833379 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,622...31,668,931
Ensembl chr21:31,659,622...31,668,931
JBrowse link
zinc acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 multiple interactions ISO [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [NR1H4 protein binds to ABCB11 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to ABCB11 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of ABCB11 mRNA CTD PMID:26241054 NCBI chr 2:168,915,468...169,031,396
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of AGL mRNA
Zinc Acetate results in decreased expression of AGL mRNA
CTD PMID:16357179 NCBI chr 1:99,850,077...99,924,023
Ensembl chr 1:99,850,361...99,924,023
JBrowse link
G ALAD aminolevulinate dehydratase increases activity
multiple interactions
ISO Zinc Acetate results in increased activity of ALAD protein
[Zinc Acetate results in increased activity of ALAD protein] which results in increased chemical synthesis of Porphobilinogen; Zinc Acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]
CTD PMID:21360559 NCBI chr 9:113,386,312...113,401,301
Ensembl chr 9:113,386,312...113,401,290
JBrowse link
G ALDH5A1 aldehyde dehydrogenase 5 family member A1 multiple interactions
increases expression
EXP motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of ALDH5A1 mRNA] CTD PMID:16357179 NCBI chr 6:24,494,969...24,537,207
Ensembl chr 6:24,494,867...24,537,207
JBrowse link
G ALDH6A1 aldehyde dehydrogenase 6 family member A1 multiple interactions
increases expression
EXP Zinc Acetate inhibits the reaction [motexafin gadolinium results in decreased expression of ALDH6A1 mRNA]
Zinc Acetate results in increased expression of ALDH6A1 mRNA
CTD PMID:16357179 NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
JBrowse link
G ARHGAP17 Rho GTPase activating protein 17 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ARHGAP17 mRNA
Zinc Acetate results in decreased expression of ARHGAP17 mRNA
CTD PMID:16357179 NCBI chr16:24,919,389...25,015,601
Ensembl chr16:24,919,389...25,015,666
JBrowse link
G ATF3 activating transcription factor 3 multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of ATF3 mRNA] CTD PMID:16357179 NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
JBrowse link
G ATM ATM serine/threonine kinase multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of ATM mRNA] CTD PMID:16357179 NCBI chr11:108,222,484...108,369,102
Ensembl chr11:108,222,832...108,369,102
Ensembl chr11:108,222,832...108,369,102
JBrowse link
G ATP7B ATPase copper transporting beta increases response to substance
multiple interactions
ISO ATP7B gene mutant form results in increased susceptibility to Zinc Acetate
[ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [NR1H4 protein binds to ABCB11 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to ABCB11 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to NR0B2 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of ABCB11 mRNA; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of NR0B2 mRNA; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of RXRA mRNA
CTD PMID:26241054 NCBI chr13:51,932,669...52,012,130
Ensembl chr13:51,930,436...52,012,125
JBrowse link
G ATR ATR serine/threonine kinase multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA
Zinc Acetate results in decreased expression of ATR mRNA
CTD PMID:16357179 NCBI chr 3:142,449,235...142,578,793
Ensembl chr 3:142,449,007...142,578,733
JBrowse link
G BACH1 BTB domain and CNC homolog 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BACH1 mRNA
Zinc Acetate results in increased expression of BACH1 mRNA
CTD PMID:16357179 NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
JBrowse link
G BAG3 BAG cochaperone 3 multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of BAG3 mRNA] CTD PMID:16357179 NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,370...119,677,819
Ensembl chr10:119,651,370...119,677,819
JBrowse link
G BBC3 BCL2 binding component 3 multiple interactions EXP [Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein] CTD PMID:20530418 NCBI chr19:47,220,822...47,232,998
Ensembl chr19:47,220,822...47,232,766
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of BIRC5 mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA]
CTD PMID:16357179 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BMT2 base methyltransferase of 25S rRNA 2 homolog multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BMT2 mRNA
Zinc Acetate results in increased expression of BMT2 mRNA
CTD PMID:16357179 NCBI chr 7:112,819,147...112,939,875
Ensembl chr 7:112,819,147...112,939,875
JBrowse link
G BNIP3 BCL2 interacting protein 3 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA
Zinc Acetate results in increased expression of BNIP3 mRNA
CTD PMID:16357179 NCBI chr10:131,967,683...131,982,013
Ensembl chr10:131,966,455...131,982,013
JBrowse link
G BNIP3L BCL2 interacting protein 3 like multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3L mRNA
Zinc Acetate results in increased expression of BNIP3L mRNA
CTD PMID:16357179 NCBI chr 8:26,383,054...26,413,127
Ensembl chr 8:26,383,054...26,505,636
JBrowse link
G CANX calnexin increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of CANX mRNA
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CANX mRNA
CTD PMID:16357179 NCBI chr 5:179,678,646...179,731,641
Ensembl chr 5:179,678,628...179,731,641
JBrowse link
G CASP3 caspase 3 multiple interactions
decreases expression
ISO
EXP
[Taurine co-treated with Zinc Acetate] inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]
Zinc Acetate results in decreased expression of CASP3 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CASP3 mRNA
CTD PMID:16357179, PMID:26335259 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CBFB core-binding factor subunit beta increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of CBFB mRNA
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CBFB mRNA
CTD PMID:16357179 NCBI chr16:67,029,149...67,101,058
Ensembl chr16:67,028,984...67,101,058
JBrowse link
G CCNJ cyclin J multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CCNJ mRNA
Zinc Acetate results in decreased expression of CCNJ mRNA
CTD PMID:16357179 NCBI chr10:96,042,848...96,060,870
Ensembl chr10:96,043,394...96,060,870
JBrowse link
G CDC16 cell division cycle 16 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA
Zinc Acetate results in decreased expression of CDC16 mRNA
CTD PMID:16357179 NCBI chr13:114,234,897...114,272,723
Ensembl chr13:114,234,887...114,272,723
JBrowse link
G CDC25C cell division cycle 25C multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDC25C mRNA
Zinc Acetate results in increased expression of CDC25C mRNA
CTD PMID:16357179 NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,265...138,338,355
JBrowse link
G CDC27 cell division cycle 27 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of CDC27 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA
CTD PMID:16357179 NCBI chr17:47,117,703...47,189,295
Ensembl chr17:47,117,703...47,189,422
JBrowse link
G CDC5L cell division cycle 5 like decreases expression
multiple interactions
EXP Zinc Acetate results in decreased expression of CDC5L mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC5L mRNA
CTD PMID:16357179 NCBI chr 6:44,387,706...44,450,425
Ensembl chr 6:44,387,706...44,450,425
JBrowse link
G CDCA2 cell division cycle associated 2 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDCA2 mRNA
Zinc Acetate results in decreased expression of CDCA2 mRNA
CTD PMID:16357179 NCBI chr 8:25,458,557...25,511,308
Ensembl chr 8:25,459,199...25,507,911
JBrowse link
G CDK19 cyclin dependent kinase 19 increases expression EXP Zinc Acetate results in increased expression of CDK19 mRNA CTD PMID:16357179 NCBI chr 6:110,609,978...110,816,531
Ensembl chr 6:110,609,978...110,815,958
JBrowse link
G CDK2 cyclin dependent kinase 2 multiple interactions
increases expression
EXP motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of CDK2 mRNA] CTD PMID:16357179 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions EXP [Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mRNA] CTD PMID:20530418 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,339
Ensembl chr 6:36,676,460...36,687,339
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA
Zinc Acetate results in increased expression of CDKN1B mRNA
CTD PMID:16357179 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,715,058...12,722,369
JBrowse link
G CTH cystathionine gamma-lyase increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of CTH mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CTH mRNA
CTD PMID:16357179 NCBI chr 1:70,411,268...70,441,949
Ensembl chr 1:70,411,218...70,439,851
JBrowse link
G CUL3 cullin 3 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CUL3 mRNA
Zinc Acetate results in decreased expression of CUL3 mRNA
CTD PMID:16357179 NCBI chr 2:224,470,150...224,585,363
Ensembl chr 2:224,470,150...224,585,397
JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 increases secretion EXP Zinc Acetate results in increased secretion of CXCL1 protein CTD PMID:21974847 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions
increases secretion
increases expression
EXP 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Zinc Acetate results in increased expression of CXCL8 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Zinc Acetate results in increased expression of CXCL8 protein]; MYD88 mutant form inhibits the reaction [Zinc Acetate results in increased expression of CXCL8 protein]
Zinc Acetate results in increased secretion of CXCL8 protein
CTD PMID:21974847, PMID:24080332 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,541...73,743,716
JBrowse link
G CYB5R1 cytochrome b5 reductase 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of CYB5R1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CYB5R1 mRNA
CTD PMID:16357179 NCBI chr 1:202,961,873...202,967,257
Ensembl chr 1:202,961,873...202,967,275
JBrowse link
G DAPK3 death associated protein kinase 3 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of DAPK3 mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DAPK3 mRNA]
CTD PMID:16357179 NCBI chr19:3,958,453...3,971,099
Ensembl chr19:3,958,453...3,971,123
JBrowse link
G DDIT3 DNA damage inducible transcript 3 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DDIT3 mRNA] CTD PMID:16357179 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DDIT4 DNA damage inducible transcript 4 multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of DDIT4 mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of DDIT4 mRNA] CTD PMID:16357179 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,924...72,276,036
JBrowse link
G DEDD2 death effector domain containing 2 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of DEDD2 mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DEDD2 mRNA]
CTD PMID:16357179 NCBI chr19:42,198,598...42,220,152
Ensembl chr19:42,198,598...42,220,140
JBrowse link
G DFFB DNA fragmentation factor subunit beta multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of DFFB mRNA
Zinc Acetate results in decreased expression of DFFB mRNA
CTD PMID:16357179 NCBI chr 1:3,857,286...3,885,429
Ensembl chr 1:3,857,267...3,885,429
JBrowse link
G DHCR7 7-dehydrocholesterol reductase decreases expression EXP Zinc Acetate results in decreased expression of DHCR7 mRNA CTD PMID:16357179 NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
JBrowse link
G DNAJB1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression
multiple interactions
EXP Zinc Acetate results in decreased expression of DNAJB1 mRNA
motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA]
CTD PMID:16357179 NCBI chr19:14,514,769...14,530,597
Ensembl chr19:14,514,769...14,529,770
JBrowse link
G DNAJB4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA
Zinc Acetate results in increased expression of DNAJB4 mRNA
CTD PMID:16357179 NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
JBrowse link
G DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB6 mRNA
Zinc Acetate results in increased expression of DNAJB6 mRNA
CTD PMID:16357179 NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439
JBrowse link
G DNAJC3 DnaJ heat shock protein family (Hsp40) member C3 multiple interactions
increases expression
EXP motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of DNAJC3 mRNA] CTD PMID:16357179 NCBI chr13:95,677,139...95,794,988
Ensembl chr13:95,677,139...95,794,988
JBrowse link
G DRD1 dopamine receptor D1 multiple interactions ISO Zinc Acetate inhibits the reaction [SCH 23390 binds to DRD1 protein] CTD PMID:9109525 NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
JBrowse link
G DRD2 dopamine receptor D2 multiple interactions ISO Zinc Acetate inhibits the reaction [3-N-methylspiperone binds to DRD2 protein] CTD PMID:9109525 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G DUSP1 dual specificity phosphatase 1 multiple interactions ISO [Taurine co-treated with Zinc Acetate] results in increased expression of DUSP1 mRNA; [Taurine co-treated with Zinc Acetate] results in increased expression of DUSP1 protein CTD PMID:26335259 NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
JBrowse link
G E2F1 E2F transcription factor 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of E2F1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of E2F1 mRNA
CTD PMID:16357179 NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
JBrowse link
G E2F3 E2F transcription factor 3 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of E2F3 mRNA
Zinc Acetate results in increased expression of E2F3 mRNA
CTD PMID:16357179 NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
JBrowse link
G EGLN1 egl-9 family hypoxia inducible factor 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of EGLN1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of EGLN1 mRNA
CTD PMID:16357179 NCBI chr 1:231,363,756...231,422,332
Ensembl chr 1:231,363,751...231,422,287
JBrowse link
G ELP1 elongator acetyltransferase complex subunit 1 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ELP1 mRNA
Zinc Acetate results in decreased expression of ELP1 mRNA
CTD PMID:16357179 NCBI chr 9:108,867,517...108,934,135
Ensembl chr 9:108,866,898...108,934,328
Ensembl chr 9:108,866,898...108,934,328
JBrowse link
G ENO1 enolase 1 increases expression EXP Zinc Acetate results in increased expression of ENO1 mRNA CTD PMID:16357179 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G FADD Fas associated via death domain multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of FADD mRNA
Zinc Acetate results in decreased expression of FADD mRNA
CTD PMID:16357179 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,163...70,207,390
Ensembl chr11:70,203,163...70,207,390
JBrowse link
G FAIM Fas apoptotic inhibitory molecule multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of FAIM mRNA
Zinc Acetate results in decreased expression of FAIM mRNA
CTD PMID:16357179 NCBI chr 3:138,608,099...138,633,376
Ensembl chr 3:138,608,606...138,633,376
JBrowse link
G FAM162A family with sequence similarity 162 member A increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of FAM162A mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FAM162A mRNA
CTD PMID:16357179 NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,176...122,412,334
JBrowse link
G FASN fatty acid synthase decreases expression EXP Zinc Acetate results in decreased expression of FASN mRNA CTD PMID:16357179 NCBI chr17:82,078,338...82,098,303
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G FOXO3 forkhead box O3 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FOXO3 mRNA
Zinc Acetate results in increased expression of FOXO3 mRNA
CTD PMID:16357179 NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of GCLM mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA
CTD PMID:16357179 NCBI chr 1:93,885,199...93,910,370
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GLS glutaminase multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GLS mRNA
Zinc Acetate results in decreased expression of GLS mRNA
CTD PMID:16357179 NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552
JBrowse link
G GPR146 G protein-coupled receptor 146 increases expression EXP Zinc Acetate results in increased expression of GPR146 mRNA CTD PMID:16357179 NCBI chr 7:1,044,546...1,059,261
Ensembl chr 7:1,044,546...1,059,261
JBrowse link
G GPT2 glutamic--pyruvic transaminase 2 increases expression EXP Zinc Acetate results in increased expression of GPT2 mRNA CTD PMID:16357179 NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289
JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions EXP [Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mRNA] CTD PMID:20530418 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,176...49,358,358
JBrowse link
G GSR glutathione-disulfide reductase multiple interactions
decreases activity
increases expression
EXP
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GSR mRNA
Zinc Acetate results in decreased activity of GSR protein
Zinc Acetate results in increased expression of GSR mRNA
CTD PMID:16357179, PMID:17382203 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GTF3C2 general transcription factor IIIC subunit 2 increases expression EXP Zinc Acetate results in increased expression of GTF3C2 mRNA CTD PMID:16357179 NCBI chr 2:27,325,851...27,357,376
Ensembl chr 2:27,325,849...27,357,034
JBrowse link
G HBP1 HMG-box transcription factor 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of HBP1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HBP1 mRNA
CTD PMID:16357179 NCBI chr 7:107,168,987...107,202,523
Ensembl chr 7:107,168,961...107,202,522
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions
increases expression
EXP [motexafin gadolinium co-treated with Zinc Acetate] results in increased expression of HIF1A protein
Zinc Acetate results in increased expression of HIF1A protein
CTD PMID:16357179 NCBI chr14:61,695,513...61,748,259
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HILPDA hypoxia inducible lipid droplet associated multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HILPDA mRNA
Zinc Acetate results in increased expression of HILPDA mRNA
CTD PMID:16357179 NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
JBrowse link
G HIPK1 homeodomain interacting protein kinase 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA] CTD PMID:16357179 NCBI chr 1:113,929,324...113,977,869
Ensembl chr 1:113,929,324...113,977,869
JBrowse link
G HLTF helicase like transcription factor multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of HLTF mRNA
Zinc Acetate results in decreased expression of HLTF mRNA
CTD PMID:16357179 NCBI chr 3:149,030,063...149,086,534
Ensembl chr 3:149,030,127...149,086,554
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions
increases expression
EXP
ISO
[motexafin gadolinium co-treated with Zinc Acetate] results in increased expression of HMOX1 protein; motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HMOX1 mRNA]
[Taurine co-treated with Zinc Acetate] results in increased expression of HMOX1 protein
CTD PMID:16357179, PMID:26335259 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,207
JBrowse link
G HRK harakiri, BCL2 interacting protein increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of HRK mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HRK mRNA
CTD PMID:16357179 NCBI chr12:116,856,144...116,881,441
Ensembl chr12:116,856,144...116,881,441
JBrowse link
G HSP90AB1 heat shock protein 90 alpha family class B member 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSP90AB1 mRNA
Zinc Acetate results in increased expression of HSP90AB1 mRNA
CTD PMID:16357179 NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
JBrowse link
G HSPA1A heat shock protein family A (Hsp70) member 1A multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1A mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1A mRNA] CTD PMID:16357179 NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1B mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1B mRNA] CTD PMID:16357179 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
JBrowse link
G HSPA4 heat shock protein family A (Hsp70) member 4 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSPA4 mRNA
Zinc Acetate results in increased expression of HSPA4 mRNA
CTD PMID:16357179 NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
JBrowse link
G HSPA4L heat shock protein family A (Hsp70) member 4 like multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSPA4L mRNA
Zinc Acetate results in increased expression of HSPA4L mRNA
CTD PMID:16357179 NCBI chr 4:127,781,796...127,840,733
Ensembl chr 4:127,781,821...127,840,733
JBrowse link
G HSPB1 heat shock protein family B (small) member 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HSPB1 mRNA] CTD PMID:16357179 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
JBrowse link
G HSPD1 heat shock protein family D (Hsp60) member 1 multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPD1 mRNA] CTD PMID:16357179 NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
JBrowse link
G HSPH1 heat shock protein family H (Hsp110) member 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HSPH1 mRNA] CTD PMID:16357179 NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
JBrowse link
G ICAM1 intercellular adhesion molecule 1 multiple interactions
increases expression
EXP 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Zinc Acetate results in increased expression of ICAM1 protein]; [Zinc Acetate results in increased phosphorylation of NFKBIA protein] inhibits the reaction [Zinc Acetate results in increased expression of ICAM1 protein]; MYD88 mutant form inhibits the reaction [Zinc Acetate results in increased expression of ICAM1 protein] CTD PMID:24080332 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
JBrowse link
G ID2 inhibitor of DNA binding 2 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of ID2 mRNA
Zinc Acetate results in increased expression of ID2 mRNA
CTD PMID:16357179 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
JBrowse link
G IKBKE inhibitor of nuclear factor kappa B kinase subunit epsilon multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IKBKE mRNA
Zinc Acetate results in increased expression of IKBKE mRNA
CTD PMID:16357179 NCBI chr 1:206,470,243...206,496,890
Ensembl chr 1:206,470,476...206,496,889
JBrowse link
G IL10 interleukin 10 increases secretion EXP Zinc Acetate results in increased secretion of IL10 protein CTD PMID:21974847 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO [Taurine co-treated with Zinc Acetate] results in decreased expression of IL1B protein CTD PMID:27501764 NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL6 interleukin 6 increases secretion EXP Zinc Acetate results in increased secretion of IL6 protein CTD PMID:21974847 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G IL7 interleukin 7 increases secretion EXP Zinc Acetate results in increased secretion of IL7 protein CTD PMID:21974847 NCBI chr 8:78,675,870...78,806,830
Ensembl chr 8:78,675,743...78,805,523
JBrowse link
G IRF2BP2 interferon regulatory factor 2 binding protein 2 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IRF2BP2 mRNA
Zinc Acetate results in increased expression of IRF2BP2 mRNA
CTD PMID:16357179 NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,609,525
JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of JUND mRNA
Zinc Acetate results in increased expression of JUND mRNA
CTD PMID:16357179 NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
JBrowse link
G KDM3A lysine demethylase 3A increases expression EXP Zinc Acetate results in increased expression of KDM3A mRNA CTD PMID:16357179 NCBI chr 2:86,440,647...86,492,716
Ensembl chr 2:86,440,647...86,492,716
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions ISO [Taurine co-treated with Zinc Acetate] results in decreased expression of MAPK8 protein modified form CTD PMID:27501764 NCBI chr10:48,306,673...48,439,360
Ensembl chr10:48,306,639...48,439,360
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions ISO [Taurine co-treated with Zinc Acetate] results in decreased expression of MAPK9 protein modified form CTD PMID:27501764 NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
JBrowse link
G MAPT microtubule associated protein tau multiple interactions EXP [Zinc Acetate results in decreased abundance of Copper] which results in decreased phosphorylation of MAPT protein CTD PMID:25671100 NCBI chr17:45,894,538...46,028,334
Ensembl chr17:45,894,551...46,028,334
Ensembl chr17:45,894,551...46,028,334
JBrowse link
G MDM2 MDM2 proto-oncogene multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA] CTD PMID:16357179 NCBI chr12:68,808,149...68,850,686
Ensembl chr12:68,808,177...68,850,686
JBrowse link
G MOB1A MOB kinase activator 1A increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of MOB1A mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MOB1A mRNA]
CTD PMID:16357179 NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898
JBrowse link
G MT1E metallothionein 1E increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of MT1E mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of MT1E mRNA
CTD PMID:16357179 NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
JBrowse link
G MT1F metallothionein 1F multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MT1F mRNA]; Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of MT1F mRNA] CTD PMID:16357179 NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
JBrowse link
G MT1G metallothionein 1G multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1G mRNA] CTD PMID:16357179 NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,731...56,668,065
Ensembl chr16:56,666,731...56,668,065
JBrowse link
G MT1H metallothionein 1H multiple interactions
increases expression
EXP motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1H mRNA] CTD PMID:16357179 NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
JBrowse link
G MT1HL1 metallothionein 1H like 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of MT1HL1 mRNA
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1HL1 mRNA]
CTD PMID:16357179 NCBI chr 1:237,004,103...237,004,441
Ensembl chr 1:237,004,103...237,004,441
JBrowse link
G MT1X metallothionein 1X multiple interactions
increases expression
EXP
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1X mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of MT1X mRNA]
Zinc Acetate results in increased expression of MT1 protein
CTD PMID:15306638, PMID:16357179 NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
JBrowse link
G MT2A metallothionein 2A increases expression
multiple interactions
ISO
EXP
Zinc Acetate results in increased expression of MT2 mRNA; Zinc Acetate results in increased expression of MT2 protein
Zinc Acetate results in increased expression of MT2A mRNA
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT2A mRNA]
CTD PMID:8876661, PMID:15306638, PMID:16357179 NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of MYD88 mRNA; MYD88 mutant form inhibits the reaction [Zinc Acetate results in increased expression of CXCL8 protein]; MYD88 mutant form inhibits the reaction [Zinc Acetate results in increased expression of ICAM1 protein]
Zinc Acetate results in decreased expression of MYD88 mRNA
CTD PMID:16357179, PMID:24080332 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,478...38,143,022
JBrowse link
G NADK NAD kinase multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of NADK mRNA
Zinc Acetate results in increased expression of NADK mRNA
CTD PMID:16357179 NCBI chr 1:1,751,232...1,780,509
Ensembl chr 1:1,751,232...1,780,457
JBrowse link
G NF1 neurofibromin 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of NF1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of NF1 mRNA
CTD PMID:16357179 NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116
JBrowse link
G NFKBIA NFKB inhibitor alpha increases degradation
multiple interactions
increases phosphorylation
EXP Zinc Acetate results in increased degradation of NFKBIA protein
[Zinc Acetate results in increased phosphorylation of NFKBIA protein] inhibits the reaction [Zinc Acetate results in increased expression of ICAM1 protein]
CTD PMID:21974847, PMID:24080332 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,511...35,404,749
Ensembl chr14:35,401,511...35,404,749
JBrowse link
G NISCH nischarin decreases expression EXP Zinc Acetate results in decreased expression of NISCH mRNA CTD PMID:16357179 NCBI chr 3:52,455,603...52,493,068
Ensembl chr 3:52,455,118...52,493,068
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 multiple interactions ISO [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to NR0B2 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of NR0B2 mRNA CTD PMID:26241054 NCBI chr 1:26,911,489...26,914,110
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G NR1D2 nuclear receptor subfamily 1 group D member 2 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of NR1D2 mRNA] CTD PMID:16357179 NCBI chr 3:23,945,286...23,980,618
Ensembl chr 3:23,945,286...23,980,617
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 multiple interactions ISO [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [NR1H4 protein binds to ABCB11 promoter] CTD PMID:26241054 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of P4HB mRNA] CTD PMID:16357179 NCBI chr17:81,843,159...81,860,535
Ensembl chr17:81,843,161...81,860,624
JBrowse link
G PDCD11 programmed cell death 11 decreases expression EXP Zinc Acetate results in decreased expression of PDCD11 mRNA CTD PMID:16357179 NCBI chr10:103,396,615...103,446,295
Ensembl chr10:103,396,626...103,446,294
JBrowse link
G PDCD4 programmed cell death 4 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PDCD4 mRNA
Zinc Acetate results in increased expression of PDCD4 mRNA
CTD PMID:16357179 NCBI chr10:110,871,928...110,900,006
Ensembl chr10:110,871,795...110,900,006
JBrowse link
G PDCD5 programmed cell death 5 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of PDCD5 mRNA
Zinc Acetate results in decreased expression of PDCD5 mRNA
CTD PMID:16357179 NCBI chr19:32,581,190...32,587,453
Ensembl chr19:32,581,190...32,587,453
JBrowse link
G PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB3 mRNA
Zinc Acetate results in increased expression of PFKFB3 mRNA
CTD PMID:16357179 NCBI chr10:6,144,918...6,254,648
Ensembl chr10:6,144,934...6,254,644
JBrowse link
G PFKFB4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB4 mRNA
Zinc Acetate results in increased expression of PFKFB4 mRNA
CTD PMID:16357179 NCBI chr 3:48,517,684...48,562,383
Ensembl chr 3:48,517,684...48,562,015
JBrowse link
G PGK1 phosphoglycerate kinase 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of PGK1 mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PGK1 mRNA]
CTD PMID:16357179 NCBI chr  X:78,104,248...78,129,295
Ensembl chr  X:77,910,739...78,129,295
JBrowse link
G PHTF2 putative homeodomain transcription factor 2 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PHTF2 mRNA] CTD PMID:16357179 NCBI chr 7:77,798,773...77,957,504
Ensembl chr 7:77,798,792...77,957,503
JBrowse link
G PIAS1 protein inhibitor of activated STAT 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PIAS1 mRNA] CTD PMID:16357179 NCBI chr15:68,054,315...68,193,847
Ensembl chr15:68,054,309...68,198,603
Ensembl chr15:68,054,309...68,198,603
JBrowse link
G PIK3IP1 phosphoinositide-3-kinase interacting protein 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PIK3IP1 mRNA
Zinc Acetate results in increased expression of PIK3IP1 mRNA
CTD PMID:16357179 NCBI chr22:31,281,593...31,292,534
Ensembl chr22:31,281,594...31,292,534
JBrowse link
G PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of PMAIP1 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PMAIP1 mRNA
CTD PMID:16357179 NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,948...59,904,306
Ensembl chr18:59,899,948...59,904,306
JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PRKACB mRNA
Zinc Acetate results in increased expression of PRKACB mRNA
CTD PMID:16357179 NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498
JBrowse link
G PRKCD protein kinase C delta decreases expression EXP Zinc Acetate results in decreased expression of PRKCD mRNA CTD PMID:16357179 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
JBrowse link
G PRKD2 protein kinase D2 decreases expression EXP Zinc Acetate results in decreased expression of PRKD2 mRNA CTD PMID:16357179 NCBI chr19:46,674,316...46,717,114
Ensembl chr19:46,674,275...46,717,127
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit increases expression EXP Zinc Acetate results in increased expression of PRKDC mRNA CTD PMID:16357179 NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
Ensembl chr 8:47,773,111...47,960,178
JBrowse link
G PTRH2 peptidyl-tRNA hydrolase 2 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of PTRH2 mRNA
Zinc Acetate results in decreased expression of PTRH2 mRNA
CTD PMID:16357179 NCBI chr17:59,697,306...59,707,626
Ensembl chr17:59,674,636...59,707,626
JBrowse link
G RB1 RB transcriptional corepressor 1 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of RB1 mRNA
Zinc Acetate results in decreased expression of RB1 mRNA
CTD PMID:16357179 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RCBTB2 RCC1 and BTB domain containing protein 2 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of RCBTB2 mRNA
Zinc Acetate results in decreased expression of RCBTB2 mRNA
CTD PMID:16357179 NCBI chr13:48,488,963...48,535,997
Ensembl chr13:48,488,959...48,533,256
JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of RELB mRNA
Zinc Acetate results in increased expression of RELB mRNA
CTD PMID:16357179 NCBI chr19:45,001,449...45,038,194
Ensembl chr19:45,001,449...45,038,198
JBrowse link
G RXRA retinoid X receptor alpha multiple interactions ISO [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to ABCB11 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] promotes the reaction [RXRA protein binds to NR0B2 promoter]; [ATP7B gene mutant form results in increased susceptibility to Zinc Acetate] which results in increased expression of RXRA mRNA CTD PMID:26241054 NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
JBrowse link
G SELENOW selenoprotein W multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SELENOW mRNA
Zinc Acetate results in increased expression of SELENOW mRNA
CTD PMID:16357179 NCBI chr19:47,778,703...47,784,682
Ensembl chr19:47,778,585...47,784,686
JBrowse link
G SESN2 sestrin 2 multiple interactions
increases expression
EXP [Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mRNA; [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SESN2 mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mRNA]
Zinc Acetate results in increased expression of SESN2 mRNA
CTD PMID:16357179, PMID:20530418 NCBI chr 1:28,259,452...28,282,491
Ensembl chr 1:28,259,518...28,282,491
JBrowse link
G SLC16A1 solute carrier family 16 member 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC16A1 mRNA] CTD PMID:16357179 NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,013
JBrowse link
G SLC16A6 solute carrier family 16 member 6 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of SLC16A6 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC16A6 mRNA
CTD PMID:16357179 NCBI chr17:68,267,026...68,291,439
Ensembl chr17:68,267,026...68,291,267
JBrowse link
G SLC1A4 solute carrier family 1 member 4 increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of SLC1A4 mRNA
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC1A4 mRNA]
CTD PMID:16357179 NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
JBrowse link
G SLC30A1 solute carrier family 30 member 1 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC30A1 mRNA]; Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC30A1 mRNA] CTD PMID:16357179 NCBI chr 1:211,571,568...211,579,161
Ensembl chr 1:211,571,568...211,579,161
JBrowse link
G SLC31A1 solute carrier family 31 member 1 increases expression EXP Zinc Acetate results in increased expression of SLC31A1 mRNA CTD PMID:24132751 NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
JBrowse link
G SLC38A2 solute carrier family 38 member 2 multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC38A2 mRNA]; Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC38A2 mRNA] CTD PMID:16357179 NCBI chr12:46,358,188...46,372,774
Ensembl chr12:46,358,188...46,372,773
JBrowse link
G SLC39A10 solute carrier family 39 member 10 affects expression
multiple interactions
EXP Zinc Acetate affects the expression of SLC39A10 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA
CTD PMID:16357179 NCBI chr 2:195,575,944...195,737,701
Ensembl chr 2:195,575,977...195,737,702
JBrowse link
G SLC39A14 solute carrier family 39 member 14 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A14 mRNA
Zinc Acetate results in increased expression of SLC39A14 mRNA
CTD PMID:16357179 NCBI chr 8:22,367,278...22,434,129
Ensembl chr 8:22,367,249...22,434,129
JBrowse link
G SLC39A9 solute carrier family 39 member 9 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC39A9 mRNA
Zinc Acetate results in increased expression of SLC39A9 mRNA
CTD PMID:16357179 NCBI chr14:69,398,374...69,462,390
Ensembl chr14:69,398,015...69,462,390
JBrowse link
G SLC3A2 solute carrier family 3 member 2 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC3A2 mRNA
Zinc Acetate results in increased expression of SLC3A2 mRNA
CTD PMID:16357179 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,102...62,888,875
JBrowse link
G SLC43A1 solute carrier family 43 member 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC43A1 mRNA
Zinc Acetate results in increased expression of SLC43A1 mRNA
CTD PMID:16357179 NCBI chr11:57,484,531...57,516,561
Ensembl chr11:57,484,534...57,515,780
JBrowse link
G SLC7A1 solute carrier family 7 member 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A1 mRNA
Zinc Acetate results in increased expression of SLC7A1 mRNA
CTD PMID:16357179 NCBI chr13:29,509,410...29,595,688
Ensembl chr13:29,509,414...29,595,688
JBrowse link
G SLC7A11 solute carrier family 7 member 11 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A11 mRNA
Zinc Acetate results in increased expression of SLC7A11 mRNA
CTD PMID:16357179 NCBI chr 4:138,164,097...138,242,349
Ensembl chr 4:138,164,097...138,242,349
JBrowse link
G SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA4 mRNA
Zinc Acetate results in decreased expression of SMARCA4 mRNA
CTD PMID:16357179 NCBI chr19:10,960,997...11,062,277
Ensembl chr19:10,960,932...11,079,426
Ensembl chr19:10,960,932...11,079,426
JBrowse link
G SMARCA5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA5 mRNA
Zinc Acetate results in decreased expression of SMARCA5 mRNA
CTD PMID:16357179 NCBI chr 4:143,513,501...143,557,486
Ensembl chr 4:143,513,702...143,557,486
JBrowse link
G SP1 Sp1 transcription factor increases expression EXP Zinc Acetate results in increased expression of SP1 mRNA CTD PMID:24132751 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
JBrowse link
G TAGAP T cell activation RhoGTPase activating protein multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TAGAP mRNA
Zinc Acetate results in increased expression of TAGAP mRNA
CTD PMID:16357179 NCBI chr 6:159,034,481...159,044,991
Ensembl chr 6:159,034,468...159,045,152
JBrowse link
G TFRC transferrin receptor multiple interactions
increases expression
EXP motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of TFRC mRNA] CTD PMID:16357179 NCBI chr 3:196,018,694...196,082,123
Ensembl chr 3:196,027,183...196,082,096
JBrowse link
G TNFAIP8 TNF alpha induced protein 8 decreases expression
multiple interactions
EXP Zinc Acetate results in decreased expression of TNFAIP8 mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFAIP8 mRNA
CTD PMID:16357179 NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688
JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TNFRSF10B mRNA
Zinc Acetate results in increased expression of TNFRSF10B mRNA
CTD PMID:16357179 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
JBrowse link
G TNFRSF17 TNF receptor superfamily member 17 multiple interactions
decreases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA
Zinc Acetate results in decreased expression of TNFRSF17 mRNA
CTD PMID:16357179 NCBI chr16:11,965,210...11,968,068
Ensembl chr16:11,965,210...11,968,068
JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of TNFRSF1A mRNA
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TNFRSF1A mRNA
CTD PMID:16357179 NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
JBrowse link
G TNFSF8 TNF superfamily member 8 multiple interactions
increases expression
EXP motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of TNFSF8 mRNA] CTD PMID:16357179 NCBI chr 9:114,893,343...114,930,674
Ensembl chr 9:114,893,343...114,930,595
JBrowse link
G TNIP2 TNFAIP3 interacting protein 2 decreases expression EXP Zinc Acetate results in decreased expression of TNIP2 mRNA CTD PMID:16357179 NCBI chr 4:2,741,648...2,756,336
Ensembl chr 4:2,741,648...2,756,342
JBrowse link
G TP53 tumor protein p53 multiple interactions EXP [Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein; Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein] CTD PMID:20530418 NCBI chr17:7,668,402...7,687,550
Ensembl chr17:7,661,779...7,687,538
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TRIB3 tribbles pseudokinase 3 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TRIB3 mRNA
Zinc Acetate results in increased expression of TRIB3 mRNA
CTD PMID:16357179 NCBI chr20:380,629...397,559
Ensembl chr20:362,835...397,559
JBrowse link
G TXNRD1 thioredoxin reductase 1 multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TXNRD1 mRNA
Zinc Acetate results in increased expression of TXNRD1 mRNA
CTD PMID:16357179 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
G UGT2B17 UDP glucuronosyltransferase family 2 member B17 multiple interactions ISO [Taurine co-treated with Zinc Acetate] results in increased expression of UGT2B1 mRNA CTD PMID:26335259 NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,184...68,568,527
JBrowse link
G VEGFA vascular endothelial growth factor A multiple interactions
increases expression
EXP [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of VEGFA mRNA
Zinc Acetate results in increased expression of VEGFA mRNA
CTD PMID:16357179 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VHL von Hippel-Lindau tumor suppressor increases expression
multiple interactions
EXP Zinc Acetate results in increased expression of VHL mRNA
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of VHL mRNA]
CTD PMID:16357179 NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,008...10,152,220
Ensembl chr 3:10,141,008...10,152,220
JBrowse link
G ZNF200 zinc finger protein 200 decreases expression EXP Zinc Acetate results in decreased expression of ZNF200 mRNA CTD PMID:16357179 NCBI chr16:3,222,325...3,236,221
Ensembl chr16:3,222,325...3,236,221
JBrowse link
G ZNF302 zinc finger protein 302 increases expression EXP Zinc Acetate results in increased expression of ZNF302 mRNA CTD PMID:16357179 NCBI chr19:34,677,648...34,686,396
Ensembl chr19:34,677,639...34,686,397
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 24359
    chemical entity 24327
      molecular entity 24285
        ion 17195
          cation 16972
            salt 15663
              organic salt 2447
                acetate salt 182
                  (2S)-2-Ethylhexyl acetate 0
                  1-dodecylguanidine acetate 0
                  L-arginyl-L-glutamic acid monoacetate 0
                  ammonium acetate 13
                  caspofungin acetate 0
                  ceftaroline fosamil acetate + 0
                  cetrorelix acetate 0
                  cobalt(II) acetate 1
                  desmopressin acetate (anhydrous) + 0
                  flecainide acetate 0
                  histrelin acetate 0
                  icatibant acetate 0
                  lead tetraacetate 6
                  leuprolide acetate 0
                  lithium acetate 0
                  peginesatide acetate 0
                  praseodymium acetate 0
                  saxitoxin acetate 0
                  thallium(I) acetate 1
                  tris acetate 0
                  zinc acetate 164
Path 2
Term Annotations click to browse term
  CHEBI ontology 24359
    subatomic particle 24315
      composite particle 24315
        hadron 24315
          baryon 24315
            nucleon 24315
              atomic nucleus 24315
                atom 24315
                  group 24209
                    polyatomic entity 24209
                      heteroatomic molecular entity 23798
                        salt 15663
                          organic salt 2447
                            acetate salt 182
                              (2S)-2-Ethylhexyl acetate 0
                              1-dodecylguanidine acetate 0
                              L-arginyl-L-glutamic acid monoacetate 0
                              ammonium acetate 13
                              caspofungin acetate 0
                              ceftaroline fosamil acetate + 0
                              cetrorelix acetate 0
                              cobalt(II) acetate 1
                              desmopressin acetate (anhydrous) + 0
                              flecainide acetate 0
                              histrelin acetate 0
                              icatibant acetate 0
                              lead tetraacetate 6
                              leuprolide acetate 0
                              lithium acetate 0
                              peginesatide acetate 0
                              praseodymium acetate 0
                              saxitoxin acetate 0
                              thallium(I) acetate 1
                              tris acetate 0
                              zinc acetate 164
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.